Cargando…
Molecular Mechanisms of Noncoding RNA in the Occurrence of Castration-Resistant Prostate Cancer
Although several therapeutic options have been shown to improve survival of most patients with prostate cancer, progression to castration-refractory state continues to present challenges in clinics and scientific research. As a highly heterogeneous disease entity, the mechanisms of castration-resist...
Autores principales: | Lin, Yu, Tan, Haisong, Yu, Guopeng, Zhan, Ming, Xu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860629/ https://www.ncbi.nlm.nih.gov/pubmed/36674820 http://dx.doi.org/10.3390/ijms24021305 |
Ejemplares similares
-
LPCAT1 enhances castration resistant prostate cancer progression via increased mRNA synthesis and PAF production
por: Han, Chao, et al.
Publicado: (2020) -
Molecular and cellular mechanisms of castration resistant prostate cancer
por: Huang, Yiqiao, et al.
Publicado: (2018) -
Targeting molecular resistance in castration-resistant prostate cancer
por: Chandrasekar, Thenappan, et al.
Publicado: (2015) -
The long noncoding RNA
HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program
por: Parolia, Abhijit, et al.
Publicado: (2019) -
Based on network pharmacology and molecular docking to predict the mechanism of Huangqi in the treatment of castration-resistant prostate cancer
por: Lin, Zesen, et al.
Publicado: (2022)